Presentation TCT 2014 Apixaban in ACS and Atrial Fibrillation: Comparison to Warfarin and Aspirin Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, Christopher B. Granger September 15, 2014
Presentation TCT 2014 Rivaroxaban in ACS and Atrial Fibrillation: Randomized Trials, Real-World Data, and Pioneering Efforts Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson September 15, 2014
Presentation TCT 2014 TCT 532: Economic Outcomes of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons vs Standard PTA: 1-Year Results from the IN.PACT SFA II Trial Presenter: Peter A. Schneider, Gunnar Tepe, Michael H. Wholey, Adam Salisbury, MD September 15, 2014
Presentation TCT 2014 Dabigatran in ACS and Atrial Fibrillation: MI Risks, Safety in the Elderly, and the RE-DUAL Trial Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, Laura Mauri September 15, 2014
Presentation TCT 2014 Comparative Analysis of Warfarin and the NOACs: Differentiating Properties, Risks, and Benefits Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, Jonathan L. Halperin September 15, 2014
Presentation TCT 2014 The REG1 Anticoagulation System: Factor IX Inhibitor Using RNA Aptamer Technology Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, A. Michael Lincoff September 15, 2014
Presentation TCT 2014 Con: Ignore Aortic Regurgitation at Your Own Risk! Presenter: Simon Redwood, Michael J. Mack September 15, 2014
Presentation TCT 2014 The Triple Therapy Conundrum: Treatment of the PCI Patient with Atrial Fibrillation Presenter: Matthew J. Price, C. Michael Gibson September 15, 2014
Presentation TCT 2014 Bleeding and Stroke Risk Assessment in Atrial Fibrillation: Choosing between Warfarin, NOACS, Antiplatelets, or Nothing? Presenter: Matthew J. Price, Michael D. Ezekowitz September 15, 2014
Presentation TCT 2014 The Five Multislice CT Essentials for Optimal TAVR Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Jonathon A. Leipsic September 14, 2014
Presentation TCT 2014 The Five Echocardiographic Essentials for Optimal TAVR Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Rebecca T. Hahn September 14, 2014
Presentation TCT 2014 Multi-device Patient-Specific TAVR Now or in the Future? Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Raj Makkar September 14, 2014
Presentation TCT 2014 TCT 404: First Clinical Experience with Neurotropic Agents for Treatment of Sympathetic Hypertension Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi September 14, 2014
Presentation TCT 2014 Special Attributes and Disadvantages of the Balloon-Expandable TAVR Platform Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, John G. Webb September 14, 2014
Presentation TCT 2014 Special Attributes and Disadvantages of the Self-Expanding TAVR Platform Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Nicolo Piazza September 14, 2014
Presentation TCT 2014 TCT 310: Recanalization Of Chronic Total Coronary Occlusions: The Influence on Collateral Donor Artery Physiology and Fractional Flow Reserve Presenter: William F. Fearon, Bon-Kwon Koo, Michael J. Lim, Andrew Ladwiniec September 14, 2014
Presentation TCT 2014 Extravascular Focused Ultrasound for Renal Denervation: Kona Medical Update Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, John A. Ormiston September 14, 2014
Presentation TCT 2014 TCT 309: Influence of Subtended Myocardial Mass on Intracoronary Physiology Indices of Stenosis Severity and Microcirculatory Function Presenter: William F. Fearon, Bon-Kwon Koo, Michael J. Lim, Mauro Echavarria-Pinto September 14, 2014
Presentation TCT 2014 TCT 406: Renal Artery Trauma Induced by Four Different Renal Denervation Systems: A Multimodality Intraarterial Imaging Study Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Antonios Karanasos September 14, 2014